Amendment to Schedule 13D by Yunqi Capital Limited Regarding STAAR Surgical Co Merger

Yunqi Capital Limited and other Reporting Persons have filed an amendment to their Schedule 13D regarding their investment in STAAR Surgical Co. The amendment details their opposition to the proposed merger with Alcon, citing concerns over the valuation of the company and the process leading to the merger agreement. The Reporting Persons believe that the merger significantly undervalues STAAR Surgical Co, particularly in light of its performance and outlook in China. They have issued press releases and open letters to stockholders outlining their reasons for opposing the merger and intend to vote against it at the upcoming special meeting of stockholders. The Reporting Persons may also consider other actions to enhance shareholder value, including engaging with management, the board, and other stakeholders.